E-ALPHA

What this means for you

Registered since 26 Sept 2017. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

87182079

Registration number

5298051

Mark type

Stylized text

Filed

23 Sept 2016

Published for opposition

21 Feb 2017

Registered

26 Sept 2017

Attorney of record

Otto O. Lee

Goods and services

• Class 042 — Scientific and technological services: Medical and scientific research in the field of oncology and immunology; Medical and scientific research in the field of immunotherapy and antibodies; Medical research services in the field of cancer; Medical and scientific research in the field of phage display and anti-cancer drug discovery; Medical and scientific research for the identification, preparation, and development of phage and antibody libraries; DNA, protein, and antibody screening for scientific research purposes

Owner

• EUREKA THERAPEUTICS, INC., EMERYVILLE, CA, US
• Eureka Therapeutics, Inc., Emeryville, CA, US
• Eureka Therapeutics, Inc., Emeryville, CA, US
• Eureka Therapeutics, Inc., Emeryville, CA, US

Prosecution history

• 21 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 21 Mar 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 21 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 26 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
• 26 Sept 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 03 Mar 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 26 Sept 2017 — REGISTERED-PRINCIPAL REGISTER
• 24 Aug 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 23 Aug 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 22 Aug 2017 — STATEMENT OF USE PROCESSING COMPLETE
• 26 Jul 2017 — USE AMENDMENT FILED
• 18 Aug 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 26 Jul 2017 — TEAS STATEMENT OF USE RECEIVED
• 18 Apr 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 21 Feb 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED